PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative EBIT growth while ANO.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.00%
Negative operating income growth while ANO.AX is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-0.00%
Negative net income growth while ANO.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-33.33%
Negative EPS growth while ANO.AX is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-33.33%
Negative diluted EPS growth while ANO.AX is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.40%
Share change of 0.40% while ANO.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
FCF growth of 0.00% while ANO.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-68.05%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-25.04%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
8.04%
3Y revenue/share CAGR under 50% of ANO.AX's 109.64%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
122.08%
OCF/share CAGR of 122.08% while ANO.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
232.93%
OCF/share CAGR of 232.93% while ANO.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
298.27%
3Y OCF/share CAGR of 298.27% while ANO.AX is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
125.52%
Net income/share CAGR 1.25-1.5x ANO.AX's 110.66%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
624.30%
5Y net income/share CAGR above 1.5x ANO.AX's 119.46%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
183.28%
3Y net income/share CAGR 50-75% of ANO.AX's 362.00%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4375.96%
3Y equity/share CAGR above 1.5x ANO.AX's 36.69%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.40%
We have a declining book value while ANO.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
1.55%
R&D growth of 1.55% while ANO.AX is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
No Data
No Data available this quarter, please select a different quarter.